- Financial Times•yesterday
Cave canem, even pooches. The Competition and Markets Authority has fined US drug titan Pfizer £84m for unfairly propelling the price of a must-have anti-epilepsy drug skyward. It is the biggest fine levied ...
The U.K. regulator takes exception to the sale of Epanutin to Flynn Pharma, which drove the price up by 2,600%.
- Motley Fool•2 days ago
A tough stock may be finally getting ahead.
GSK.L : Summary for GLAXOSMITHKLINE PLC ORD 25P - Yahoo Finance
GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
|Bid||1,450.00 x 175400|
|Ask||1,475.00 x 417900|
|Day's Range||1,456.81 - 1,470.00|
|52 Week Range||1,277.25 - 1,745.56|
|PE Ratio (TTM)||239.34|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|